Amyotrophic lateral sclerosis

Amyotrophic lateral sclerosis

Several distinct molecular mechanisms may play a role in motor neuron degeneration. In approximately 10% of patients, amytrophic lateral sclerosis (ALS) occurs in families with an autosomal dominant mode of inheritance caused by mutations in genes that appear functionally heterogeneous. Sporadic ALS is considered a complex multifactorial disease with interplay of genetic and environmental factors affecting susceptibility and clinical expression.

The goal of our research is to develop effective treatment for patients with ALS, by delineating molecular pathways that drive motor neuron degeration using data and samples obtained from patients, transgenic ALS mice and neuronal cell culture models. To reach this goal we use several approaches which are described here.

Thank you for your review!

Has this information helped you?

Please tell us why, so that we can improve our website.

Working at UMC Utrecht





Practical uses cookies

This website uses cookies This website displays videos from, among others, YouTube. Such parties place cookies (third-party cookies). If you do not want these cookies, you can indicate that here. We also place cookies ourselves to improve our site.

Read more about the cookie policy

Agree No, rather not